Viewing Study NCT03747315



Ignite Creation Date: 2024-05-06 @ 12:23 PM
Last Modification Date: 2024-10-26 @ 12:58 PM
Study NCT ID: NCT03747315
Status: COMPLETED
Last Update Posted: 2021-06-08
First Post: 2018-11-14

Brief Title: A Diagnostic Test for Familial Mediterranean Fever
Sponsor: Hospices Civils de Lyon
Organization: Hospices Civils de Lyon

Study Overview

Official Title: Assessment of a Functional Test to Detect Familial Mediterranean Fever
Status: COMPLETED
Status Verified Date: 2021-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: DEPIST-FMF
Brief Summary: Familial Mediterranean Fever FMF is the most common auto-inflammatory disease prevalence 1-5 10000 inhabitants It is due to mutations of the MEFV gene encoding variants of the Pyrin inflammasome Inflammasomes are protein complexes of innate immunity producing pro-inflammatory cytokines interleukin-1β

In vitro preliminary results demonstrated that activation of the Pyrin inflammasome measured by interleukin-1β concentration by kinase inhibitors is significantly increased in FMF patients compared to subjects with a similar clinical picture and healthy controls In addition a measure of cell death yielded significant results in differentiating patients from controls

The investigators hypothesize that this fast and simple functional test can serve as a diagnostic tool for FMF
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None